The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase (Ph) I study of the safety and efficacy of the cMET inhibitor capmatinib (INC280) in patients (pts) with advanced cMET+ non-small cell lung cancer (NSCLC).
 
Martin H. Schuler
Honoraria - Alexion Pharmaceuticals; Boehringer Ingelheim; Celgene; GlaxoSmithKline; Lilly; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Inanovate; Lilly; Novartis
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - University Duisberg-Essen
Travel, Accommodations, Expenses - Alexion Pharmaceuticals; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Inanovate; Lilly; Pfizer
 
Rossana Berardi
Consulting or Advisory Role - Bayer; Italfarmaco; Lilly; Otsuka
 
Wan-Teck Lim
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis
 
Robin Van Geel
No Relationships to Disclose
 
Maja J. De Jonge
No Relationships to Disclose
 
Todd Michael Bauer
No Relationships to Disclose
 
Analia Azaro
No Relationships to Disclose
 
Maya Gottfried
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche
 
Ji-Youn Han
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD
Speakers' Bureau - AstraZeneca; Roche
Research Funding - Boehringer Ingelheim; Roche
 
Dae Ho Lee
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Pfizer; Samsung
 
Mira Wollner
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim
Travel, Accommodations, Expenses - MSD; Roche
 
David S. Hong
Research Funding - Amgen; AstraZeneca; Daiichi Sankyo; Eisai; Genentech; Lilly; Merck; Mirati Therapeutics; miRNA Therapeutics; Novartis; Pfizer
Travel, Accommodations, Expenses - Loxo; miRNA Therapeutics
 
Arndt Vogel
Honoraria - Amgen; Baxalta; Bayer; Lilly; Novartis; Roche
Consulting or Advisory Role - Amgen; Baxalta; Bayer; Lilly; Roche
Travel, Accommodations, Expenses - Amgen; Bayer; Roche; Sanofi
 
Angelo Delmonte
No Relationships to Disclose
 
Alexander Krohn
No Relationships to Disclose
 
Yong Zhang
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Patents, Royalties, Other Intellectual Property - Novartis
 
Matthew Squires
Employment - Novartis
 
Monica Giovannini
Employment - Celgene; Celgene (I); Novartis; Novartis (I)
Leadership - Celgene; Celgene (I); Novartis; Novartis (I)
Stock and Other Ownership Interests - Celgene; Celgene (I); Novartis; Novartis (I)
Other Relationship - Novartis
 
Mikhail Akimov
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Yung-Jue Bang
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Novartis (Inst)